Literature DB >> 27628077

Update in Lung Cancer 2015.

Avrum Spira1, Balazs Halmos2, Charles A Powell3.   

Abstract

Mesh:

Year:  2016        PMID: 27628077      PMCID: PMC5027233          DOI: 10.1164/rccm.201604-0898UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  76 in total

1.  Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation.

Authors:  Nichole T Tanner; Mulugeta Gebregziabher; Chanita Hughes Halbert; Elizabeth Payne; Leonard E Egede; Gerard A Silvestri
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

2.  Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).

Authors:  Oscar Arrieta; Andrés F Cardona; Claudio Martín; Luis Más-López; Luis Corrales-Rodríguez; Guillermo Bramuglia; Omar Castillo-Fernandez; Matthew Meyerson; Eduardo Amieva-Rivera; Alma Delia Campos-Parra; Hernán Carranza; Juan Carlos Gómez de la Torre; Yanina Powazniak; Fernando Aldaco-Sarvide; Carlos Vargas; Mariana Trigo; Manuel Magallanes-Maciel; Jorge Otero; Roberto Sánchez-Reyes; Mauricio Cuello
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

3.  Rociletinib in EGFR-mutated non-small-cell lung cancer.

Authors:  Lecia V Sequist; Jean-Charles Soria; Jonathan W Goldman; Heather A Wakelee; Shirish M Gadgeel; Andrea Varga; Vassiliki Papadimitrakopoulou; Benjamin J Solomon; Geoffrey R Oxnard; Rafal Dziadziuszko; Dara L Aisner; Robert C Doebele; Cathy Galasso; Edward B Garon; Rebecca S Heist; Jennifer Logan; Joel W Neal; Melody A Mendenhall; Suzanne Nichols; Zofia Piotrowska; Antoinette J Wozniak; Mitch Raponi; Chris A Karlovich; Sarah Jaw-Tsai; Jeffrey Isaacson; Darrin Despain; Shannon L Matheny; Lindsey Rolfe; Andrew R Allen; D Ross Camidge
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

4.  Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.

Authors:  Fabien Maldonado; Fenghai Duan; Sushravya M Raghunath; Srinivasan Rajagopalan; Ronald A Karwoski; Kavita Garg; Erin Greco; Hrudaya Nath; Richard A Robb; Brian J Bartholmai; Tobias Peikert
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

Authors:  Nanda Horeweg; Carlijn M van der Aalst; Erik Thunnissen; Kristiaan Nackaerts; Carla Weenink; Harry J M Groen; Jan-Willem J Lammers; Joachim G Aerts; Ernst T Scholten; Joost van Rosmalen; Willem Mali; Matthijs Oudkerk; Harry J de Koning
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

7.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

8.  Racial and Ethnic Variations in Lung Cancer Incidence and Mortality: Results From the Women's Health Initiative.

Authors:  Manali I Patel; Ange Wang; Kristopher Kapphahn; Manisha Desai; Rowan T Chlebowski; Michael S Simon; Chloe E Bird; Giselle Corbie-Smith; Scarlett Lin Gomez; Lucile L Adams-Campbell; Michele L Cote; Marcia L Stefanick; Heather A Wakelee
Journal:  J Clin Oncol       Date:  2015-12-23       Impact factor: 44.544

9.  Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.

Authors:  Magdalena B Wozniak; Ghislaine Scelo; David C Muller; Anush Mukeria; David Zaridze; Paul Brennan
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

10.  Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.

Authors:  Alice T Shaw; Leena Gandhi; Shirish Gadgeel; Gregory J Riely; Jeremy Cetnar; Howard West; D Ross Camidge; Mark A Socinski; Alberto Chiappori; Tarek Mekhail; Bo H Chao; Hossein Borghaei; Kathryn A Gold; Ali Zeaiter; Walter Bordogna; Bogdana Balas; Oscar Puig; Volkmar Henschel; Sai-Hong Ignatius Ou
Journal:  Lancet Oncol       Date:  2015-12-19       Impact factor: 41.316

View more
  2 in total

1.  Genomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma.

Authors:  Jun Qian; Shilin Zhao; Yong Zou; S M Jamshedur Rahman; Maria-Fernanda Senosain; Thomas Stricker; Heidi Chen; Charles A Powell; Alain C Borczuk; Pierre P Massion
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

2.  Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease.

Authors:  Shotaro Chubachi; Saeko Takahashi; Akihiro Tsutsumi; Naofumi Kameyama; Mamoru Sasaki; Katsuhiko Naoki; Kenzo Soejima; Hidetoshi Nakamura; Koichiro Asano; Tomoko Betsuyaku
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.